|4Nov 29, 6:31 PM ET

KAY CHRISTINA 4

4 · INTEGRATED BIOPHARMA INC · Filed Nov 29, 2023

Insider Transaction Report

Form 4
Period: 2023-11-28
KAY CHRISTINA
DirectorExecutive Vice President
Transactions
  • Award

    Stock Option (right to buy)

    2023-11-28+150,000150,000 total
    Exercise: $0.26Exp: 2033-11-28Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 28, 2024.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT